Experimentica

Experimentica

Kuopio, Finland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Experimentica is a specialized preclinical CRO focused on ophthalmic and dermatological research, offering tailored in vivo models and comprehensive study services to accelerate therapeutic development. The company differentiates itself through its proprietary technology integration, including AI and advanced data analytics, and maintains high ethical standards as an AAALAC-accredited organization. With a global client base and recent facility expansion, Experimentica is positioned as a key partner in bridging the gap between preclinical discovery and clinical trials for eye diseases.

OphthalmologyDermatology

Technology Platform

Proprietary preclinical ocular disease models integrated with advanced data collection, proprietary algorithms, and artificial intelligence (AI) for enhanced analysis and predictive insights.

Funding History

2
Total raised:$2.5M
Seed$2M
Grant$500K

Opportunities

The growing global ophthalmic drug market and increasing R&D investment create strong demand for specialized preclinical services.
Expansion of its AI and data analytics capabilities offers a key differentiation and premium service layer.
The recent facility expansion provides capacity to scale operations and capture more market share.

Risk Factors

Revenue is dependent on the R&D spending cycles of biopharma clients, which can be volatile.
Competition from other specialized CROs and large full-service CROs poses a market share threat.
Operational risks include maintaining complex animal models, data quality, and specialized talent, alongside inherent reputational risks associated with animal research.

Competitive Landscape

Experimentica competes in the niche of preclinical ophthalmic CRO services against other specialized firms and the ophthalmology divisions of large, global CROs. Its differentiation lies in its deep focus on ocular models, integration of AI/analytics, and AAALAC-accredited animal welfare standards. The competitive landscape requires continuous innovation in model development and data delivery to maintain an edge.